127 related articles for article (PubMed ID: 28559816)
1. Pneumothorax during Pazopanib Treatment in Patients with Soft-Tissue Sarcoma: Two Case Reports and a Review of the Literature.
Nakahara Y; Fukui T; Katono K; Nishizawa Y; Okuma Y; Ikegami M; Sasaki J; Masuda N
Case Rep Oncol; 2017; 10(1):333-338. PubMed ID: 28559816
[TBL] [Abstract][Full Text] [Related]
2. Pneumothorax as adverse event in patients with lung metastases of soft tissue sarcoma treated with pazopanib: a single reference centre case series.
Verschoor AJ; Gelderblom H
Clin Sarcoma Res; 2014; 4():14. PubMed ID: 25302110
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for pneumothorax in advanced and/or metastatic soft tissue sarcoma patients during pazopanib treatment: a single-institute analysis.
Nakano K; Motoi N; Tomomatsu J; Gokita T; Ae K; Tanizawa T; Matsumoto S; Takahashi S
BMC Cancer; 2016 Sep; 16(1):750. PubMed ID: 27663525
[TBL] [Abstract][Full Text] [Related]
4. Pneumothorax in lung metastasis of advanced soft tissue sarcoma patients treated with oral pazopanib.
Sarkar S; Mishra PK; Mukhopadhyay S; Sen S; Biswas B
Indian J Cancer; 2023 Sep; ():. PubMed ID: 38090966
[TBL] [Abstract][Full Text] [Related]
5. A Case Report of Secondary Simultaneous Bilateral Pneumothorax Due to Pazopanib Treatment.
Çelik B; Sürücü ZP; Yılmaz V; Çelik HK
Turk Thorac J; 2018 Jan; 19(1):49-51. PubMed ID: 29404187
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of bilateral spontaneous pneumothorax during pazopanib therapy for pulmonary soft tissue sarcoma metastases. What to do when there is so few evidence?].
Agrafiotis AC; Prieto M; Verhaeghe JL; Siat J; Grosdidier G; Rios M
Rev Pneumol Clin; 2016 Oct; 72(5):293-295. PubMed ID: 27561973
[TBL] [Abstract][Full Text] [Related]
7. [Pneumothorax during Pazopanib Therapy in a Patient with Soft Tissue Sarcoma].
Kanno N; Nakahashi K; Shiikawa M; Endo M; Numahata K; Shiono S
Gan To Kagaku Ryoho; 2021 Jul; 48(7):975-977. PubMed ID: 34267040
[TBL] [Abstract][Full Text] [Related]
8. Secondary spontaneous pneumothorax in patients with sarcoma treated with Pazopanib, a case control study.
Sabath B; Muhammad HA; Balagani A; Ost DE; Vakil E; Ahmed T; Vial MR; Grosu HB
BMC Cancer; 2018 Oct; 18(1):937. PubMed ID: 30285733
[TBL] [Abstract][Full Text] [Related]
9. Tension Pneumothorax: Is it Sarcoma or Pazopanib?
Sebanayagam V; Alkassis S; Alshare B; Thati N
Cureus; 2020 Oct; 12(10):e10945. PubMed ID: 33200058
[TBL] [Abstract][Full Text] [Related]
10. Pneumothorax as an Adverse Event in Patients with Lung Metastasis of Soft Tissue Sarcoma under Eribulin Treatment.
Takada K; Murase K; Nakamura H; Hayasaka N; Arihara Y; Iyama S; Ikeda H; Emori M; Sugita S; Nakamura K; Miyanishi K; Kobune M; Kato J
Intern Med; 2019 Oct; 58(20):3009-3012. PubMed ID: 31243217
[TBL] [Abstract][Full Text] [Related]
11. The clinical outcome of pazopanib treatment in Japanese patients with relapsed soft tissue sarcoma: A Japanese Musculoskeletal Oncology Group (JMOG) study.
Nakamura T; Matsumine A; Kawai A; Araki N; Goto T; Yonemoto T; Sugiura H; Nishida Y; Hiraga H; Honoki K; Yasuda T; Boku S; Sudo A; Ueda T
Cancer; 2016 May; 122(9):1408-16. PubMed ID: 26970174
[TBL] [Abstract][Full Text] [Related]
12. Posterior reversible encephalopathy syndrome (PRES) induced by pazopanib, a multi-targeting tyrosine kinase inhibitor, in a patient with soft-tissue sarcoma: case report and review of the literature.
Deguchi S; Mitsuya K; Nakasu Y; Hayashi N; Katagiri H; Murata H; Wasa J; Takahashi M; Endo M
Invest New Drugs; 2018 Apr; 36(2):346-349. PubMed ID: 29067537
[TBL] [Abstract][Full Text] [Related]
13. Successful Treatment with Pazopanib for Multiple Lung Metastases of Inguinal Epithelioid Sarcoma: A Case Report.
Irimura S; Nishimoto K; Kikuta K; Nakayama R; Susa M; Horiuchi K; Nakamura M; Matsumoto M; Morioka H
Case Rep Oncol; 2015; 8(3):378-84. PubMed ID: 26500539
[TBL] [Abstract][Full Text] [Related]
14. Chronic active hepatitis induced by Pazopanib mimicking hypervascular liver metastases in a patient with recurrent soft tissue sarcoma: A case report.
Ezponda A; De La Huebra IG; Calvo M; Idoate MÁ; Vivas I
Oncol Lett; 2018 Sep; 16(3):4043-4048. PubMed ID: 30128026
[TBL] [Abstract][Full Text] [Related]
15. Neutrophil-to-lymphocyte ratio after pazopanib treatment predicts response in patients with advanced soft-tissue sarcoma.
Kobayashi H; Okuma T; Oka H; Hirai T; Ohki T; Ikegami M; Sawada R; Shinoda Y; Akiyama T; Sato K; Abe S; Kawano H; Goto T; Tanaka S
Int J Clin Oncol; 2018 Apr; 23(2):368-374. PubMed ID: 29086877
[TBL] [Abstract][Full Text] [Related]
16. A remarkable response to pazopanib, despite recurrent liver toxicity, in a patient with a high grade endometrial stromal sarcoma, a case report.
Verschoor AJ; Warmerdam FARM; Bosse T; Bovée JVMG; Gelderblom H
BMC Cancer; 2018 Jan; 18(1):92. PubMed ID: 29357824
[TBL] [Abstract][Full Text] [Related]
17. Pazopanib and soft-tissue sarcomas. Too toxic.
Prescrire Int; 2013 Jun; 22(139):145-7. PubMed ID: 23866345
[TBL] [Abstract][Full Text] [Related]
18. Real-World Experiences with Pazopanib in Patients with Advanced Soft Tissue and Bone Sarcoma in Northern California.
Seto T; Song MN; Trieu M; Yu J; Sidhu M; Liu CM; Sam D; Pan M
Med Sci (Basel); 2019 Mar; 7(3):. PubMed ID: 30889920
[No Abstract] [Full Text] [Related]
19. Outcome of uterine sarcoma patients treated with pazopanib: A retrospective analysis based on two European Organisation for Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group (STBSG) clinical trials 62043 and 62072.
Benson C; Ray-Coquard I; Sleijfer S; Litière S; Blay JY; Le Cesne A; Papai Z; Judson I; Schöffski P; Chawla S; Gil T; Piperno-Neumann S; Marréaud S; Dewji MR; van der Graaf WTA
Gynecol Oncol; 2016 Jul; 142(1):89-94. PubMed ID: 27012429
[TBL] [Abstract][Full Text] [Related]
20. A Case of Uterine Leiomyosarcoma with Long-Term Disease Control by Pazopanib.
Nagamata S; Ebina Y; Yamano Y; Miyamoto T; Nishijima M; Yamada H
Kobe J Med Sci; 2016 Jul; 62(2):E45-8. PubMed ID: 27578036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
